title: [Human metapneumovirus].
abstract: Respiratory viral infections are the most significant cause of increased mortality and morbidity especially in immunocompromised people. These infections are increasingly recognized as being the cause of the failure of a graft or the cause of death in both solid organ and hematopoietic stem cell transplant recipients. Treatment with potent immunosuppressive medication is necessary for regulation in order to prevent rejection of solid organs and graft-versus-host disease. As a consequence of this therapy, infections are more common. Respiratory viral infections are the most frequent and serious complications after hematopoietic stem cell transplantation (HSCT). Despite increased methods of testing for viral pathogens, nearly 10% of pneumonia in HSCT recipients still remain "idiopathic pneumonia syndrome". Recently described human metapneumovirus could be one of the etiological agents of this syndrome.
authors.affiliation: 2nd Department of Medicine, Clinical Hematology, University Hospital Hradec Králové, Hradec Králové, Czech Republic. stepaeva@fnhk.cz
authors.forename: Eva
authors.initials: E
authors.lastname: Stepánová
authors.forename: Pavel
authors.initials: P
authors.lastname: Zák
authors.forename: Vlasta
authors.initials: V
authors.lastname: Stepánová
authors.forename: Pavel
authors.initials: P
authors.lastname: Ryska
mesh_terms: D006801:Humans; D016867:Immunocompromised Host; D029121:Metapneumovirus / Q000145:classification / Q000502:physiology; D018184:Paramyxoviridae Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control